Physician profile
Jay A Meisel
NPI 1720140353
$2,389.02
in general payments reported to CMS, 2019-2025
19 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $141 · 2021: $192 · 2022: $343 · 2023: $699 · 2024: $629 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,315 · Education: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,315.19 |
| Education | $164.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $462.56 | 2019-2024 | Spaceoar Vue System - 10ml |
| Astellas Pharma US INC | $428.53 | 2019-2023 | Xtandi |
| Janssen Biotech, INC. | $318.57 | 2019-2025 | Erleada, Balversa, Akeega |
| Pfizer INC. | $192.69 | 2023-2025 | |
| Palette Life Sciences, INC. | $168.26 | 2022-2023 | |
| Tactile Systems Technology INC | $117.39 | 2022-2024 | Entre Plus, Flexitouch Plus |
| Myriad Genetic Laboratories, INC. | $116.99 | 2022-2024 | Prolaris, Myrisk |
| Amgen INC. | $114.07 | 2022-2023 | Xgeva |
| Sumitomo Pharma America, INC. | $97.90 | 2023-2025 | Orgovyx |
| Blue Earth Diagnostics | $62.72 | 2019-2022 | |
| Telix Pharmaceuticals | $54.10 | 2024 | Illuccix |
| Coherus Oncology, INC. | $52.68 | 2024 | |
| Elekta, INC. | $45.56 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $41.64 | 2022-2023 | Opdivo |
| Astrazeneca Pharmaceuticals LP | $39.02 | 2022-2023 | Tagrisso |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $26.60 | 2024 | Libtayo |
| Karl Storz Endoscopy-America | $20.00 | 2022 | |
| Accord Healthcare, INC. | $16.51 | 2025 | |
| Siemens Medical Solutions USA, INC. | $13.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Meisel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.